Expert Q&A: Developments in Noninvasive Prenatal Testing
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Malpractice Premiums Rise but Medicare Reimbursement Doesn’t
...
Lab Loses Round 1 of Reimbursement Lawsuit against Unitedhealth Group
...
Veracyte Announces Big Developments
From - Laboratory Industry Report
Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew…
Industry Newsmaker: Veracyte, Inc. Scores Big with Percepta and Affirma GEC
...